SynopsisThe global market for Chain Pharmacy Prescription Drugs was valued at US$ 35000 million in the year 2024 and is projected to reach a revised size of US$ 40370 million by 2031, growing at a CAGR of 2.1% during the forecast period. Prescription drugs play .....
SynopsisThe global market for Oncology Drugs was valued at US$ 239850 million in the year 2024 and is projected to reach a revised size of US$ 471950 million by 2031, growing at a CAGR of 10.3% during the forecast period. Cancer is the name given to a group of r.....
SynopsisThe global market for Blood Banking and Blood Products was valued at US$ 57320 million in the year 2024 and is projected to reach a revised size of US$ 91740 million by 2031, growing at a CAGR of 7.0% during the forecast period. Blood banking is the proc.....
SynopsisThe global market for Cryosurgery Units was valued at US$ 47.3 million in the year 2024 and is projected to reach a revised size of US$ 65.8 million by 2031, growing at a CAGR of 4.9% during the forecast period. Cryosurgery units are surgical instruments.....
SynopsisThe global market for Medical Specialty Enzymes was valued at US$ 924 million in the year 2024 and is projected to reach a revised size of US$ 1328 million by 2031, growing at a CAGR of 5.4% during the forecast period. Medical Specialty Enzymes contains .....
SynopsisThe global market for Cancer Respiratory Biopsy was valued at US$ 350 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 20.0% during the forecast period. Cancer respiratory biopsy is a non.....
SynopsisThe global market for Orthokeratology was valued at US$ 1827 million in the year 2024 and is projected to reach a revised size of US$ 5533 million by 2031, growing at a CAGR of 17.4% during the forecast period. Ortho-K is a non-surgical refractive treatm.....
SynopsisThe global market for Oncaspar was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 281 million by 2031, growing at a CAGR of 11.4% during the forecast period. Oncaspar is a cancer medicine used in adults and chi.....
SynopsisThe global market for Recombinant Human Glial Cell Maturation Factor β was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period. GMF-beta belo.....
SynopsisThe global market for Foot Care Products was valued at US$ 4479 million in the year 2024 and is projected to reach a revised size of US$ 6190 million by 2031, growing at a CAGR of 4.8% during the forecast period. The market for foot care products compris.....
